Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nocebo effects can make you feel pain.

Literature DB >> 28983038

Nocebo effects can make you feel pain.

Luana Colloca¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Year: 2017 PMID： 28983038 PMCID： PMC5754642 DOI： 10.1126/science.aap8488

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

× No keyword cloud information.

15 in total

1. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors: Irene Tracey
Journal: Nat Med Date: 2010-10-14 Impact factor: 53.440

2. Nocebo effects, patient-clinician communication, and therapeutic outcomes.

Authors: Luana Colloca; Damien Finniss
Journal: JAMA Date: 2012-02-08 Impact factor: 56.272

3. Commercial features of placebo and therapeutic efficacy.

Authors: Rebecca L Waber; Baba Shiv; Ziv Carmon; Dan Ariely
Journal: JAMA Date: 2008-03-05 Impact factor: 56.272

Review 4. Nonspecific medication side effects and the nocebo phenomenon.

Authors: Arthur J Barsky; Ralph Saintfort; Malcolm P Rogers; Jonathan F Borus
Journal: JAMA Date: 2002-02-06 Impact factor: 56.272

5. Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia.

Authors: A Tinnermann; S Geuter; C Sprenger; J Finsterbusch; C Büchel
Journal: Science Date: 2017-10-06 Impact factor: 47.728

Review 6. The nocebo effect and its relevance for clinical practice.

Authors: Luana Colloca; Franklin G Miller
Journal: Psychosom Med Date: 2011-08-23 Impact factor: 4.312

7. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Authors: Ajay Gupta; David Thompson; Andrew Whitehouse; Tim Collier; Bjorn Dahlof; Neil Poulter; Rory Collins; Peter Sever
Journal: Lancet Date: 2017-05-02 Impact factor: 79.321

Review 8. Overt versus covert treatment for pain, anxiety, and Parkinson's disease.

Authors: Luana Colloca; Leonardo Lopiano; Michele Lanotte; Fabrizio Benedetti
Journal: Lancet Neurol Date: 2004-11 Impact factor: 44.182

9. The role of learning in nocebo and placebo effects.

Authors: L Colloca; M Sigaudo; F Benedetti
Journal: Pain Date: 2008-03-26 Impact factor: 6.961

10. Nocebo and pain: An overview of the psychoneurobiological mechanisms.

Authors: Maxie Blasini; Nicole Corsi; Regine Klinger; Luana Colloca
Journal: Pain Rep Date: 2017 Mar-Apr

15 in total

1. The Placebo Effect in Pain Therapies.

Authors: Luana Colloca
Journal: Annu Rev Pharmacol Toxicol Date: 2018-09-14 Impact factor: 13.820

2. Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Authors: Rui-Sheng Wang; Damien C Croteau-Chonka; Edwin K Silverman; J Loscalzo; Scott T Weiss; Kathryn T Hall
Journal: Clin Pharmacol Ther Date: 2019-10-28 Impact factor: 6.875

3. Preface: The Fascinating Mechanisms and Implications of the Placebo Effect.

Authors: Luana Colloca
Journal: Int Rev Neurobiol Date: 2018 Impact factor: 3.230

4. Preface: Part II: The Fascinating Mechanisms and Implications of the Placebo Effect.

Authors: Luana Colloca
Journal: Int Rev Neurobiol Date: 2018 Impact factor: 3.230

5. COVID-19 and the Political Economy of Mass Hysteria.

Authors: Philipp Bagus; José Antonio Peña-Ramos; Antonio Sánchez-Bayón
Journal: Int J Environ Res Public Health Date: 2021-02-03 Impact factor: 4.614

6. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.

Authors: Rishi J Desai; Ameet Sarpatwari; Sara Dejene; Nazleen F Khan; Joyce Lii; James R Rogers; Sarah K Dutcher; Saeid Raofi; Justin Bohn; John G Connolly; Michael A Fischer; Aaron S Kesselheim; Joshua J Gagne
Journal: PLoS Med Date: 2019-03-13 Impact factor: 11.069

7. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Authors: Rishi J Desai; Ameet Sarpatwari; Sara Dejene; Nazleen F Khan; Joyce Lii; James R Rogers; Sarah K Dutcher; Saeid Raofi; Justin Bohn; John Connolly; Michael A Fischer; Aaron S Kesselheim; Joshua J Gagne
Journal: BMJ Date: 2018-04-03